NAFLD and adverse pregnancy outcomes
The authors explore the relationship between maternal NAFLD and adverse pregnancy outcomes in different body mass index (BMI) groups.Read More
COVID-19, mortality and NAFLD
The authors estimated chronic liver disease-related mortality trends among individuals with diabetes before and during the COVID-19 pandemic.Read More
NAFL: FIB-4, a strong predictor of both all-cause mortality and liver-related adverse outcomes
The authors analysed data on 30 million patients categorised into three diagnostic groups: NAFLD, NASH, and at risk of NASH.Read More
From NAFLD to MAFLD in terms of nurse perspective
An international consensus panel has produced an influential report renaming the disease from NAFLD to MAFLD and suggesting how the disease should be diagnosed.Read More
NAFLD/NASH: clinically relevant adipose tissue measurement techniques
The body mass index (BMI) is commonly used as a proxy measure of body fatness. However, BMI does not reflect the level and distribution of body fat. .....Read More
NAFLD: from drivers to targets
In this review, A. Santos-Laso et al. (Marqués de Valdecilla University Hospital, Valdecilla Biomedical Research Institute, Santander, Spain) summarise the key aspects of NAFLD .....Read More
NASH: an Overview Through 200 Years of Clinical Research
Although the term 'fatty liver hepatitis' first appeared in 1962, it was in 1980 that the term 'non-alcoholic steatohepatitis' (NASH) was coined and the histopathological.....Read More
Fatty liver through the ages: Nonalcoholic steatohepatitis
In this article, Z. M. Younossi et al. (Inova Health System, Falls Church, VA, USA) aimed to review the current literature on NAFLD and NASH as it impacts children and adults....Read More
Parsing the role of PPARs in macrophage processes
In this review, D. Toobian et al. (University of California San Diego, CA, USA) underline emerging evidence of the potential roles of the PPAR subtypes in macrophage.....
Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH
Mechanistic understandings of liver damage in NASH are incomplete. In this article, using a preclinical mouse model that displays key features of human NASH, M.....
Identify the risk of NASH and cirrhosis: the time to screen is now
Early screening and risk stratification for advanced liver fibrosis is critical in primary care and endocrinology clinics to prevent future cirrhosis in groups.....
Role of age, gender and ethnicity in the association between visceral adiposity index and non-alcoholic fatty liver disease among US adults (NHANES 2003-2018): cross-sectional study
In this cross-sectional population-based study, the authors aimed to explore the association between visceral adiposity index and NAFLD in the general US.....